5.1 Off-Label Waived Testing and High-Complexity Default
Key Takeaways
- Off-label or modified use of a waived test system defaults the test to high complexity (AMT CMLA I.2.B.1; CMS CLIA policy).
- Certificate of Waiver laboratories may perform only unmodified waived tests and must follow manufacturer instructions exactly (42 CFR 493.15(e)).
- CLIA complexity is waived, moderate (including provider-performed microscopy), and high; a modified waived cassette is not recategorized as moderate or PPM.
- Modifications include extra incubation, diluted samples, unapproved specimen types, homemade QC, and using expired kits "just this once."
- When complexity jumps, director, testing-personnel, QC, proficiency testing, and method-validation requirements jump with it; a CMLA must not independently perform high-complexity testing.
CMLA Work Area I.2.B.1 is a bright-line rule: "off-label use" or modified use of a waived test system defaults the test to high complexity. That sentence is how American Medical Technologists (AMT) and the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 CFR Part 493, treat a cassette you "tweaked." A Certified Medical Laboratory Assistant (CMLA) who can tell waived from moderate from high complexity can stop an uncertified test before it is reported.
Quick Answer: A Certificate of Waiver (CoW) laboratory may perform only unmodified waived tests and must follow the manufacturer's instructions for use (IFU) exactly. Extra incubation, a diluted sample, an unapproved specimen, homemade quality control (QC), or an expired kit used "just this once" makes the method high complexity. Director, personnel, QC, proficiency testing (PT), and validation requirements jump. A CMLA must not independently perform that high-complexity testing.
CLIA complexity: waived, moderate, and high
The Food and Drug Administration (FDA) categorizes commercially marketed tests. The Centers for Medicare & Medicaid Services (CMS) issues the CLIA certificate that must match what the laboratory actually performs.
| Category | What it means | Typical CLIA certificate | CMLA performance |
|---|---|---|---|
| Waived | Simple tests with an insignificant risk of an erroneous result (42 CFR 493.15); FDA-waived or cleared for home use | Certificate of Waiver if the lab does only waived testing | Yes — follow the IFU exactly |
| Moderate complexity | Score ≤12 on CLIA's seven criteria (42 CFR 493.17); includes provider-performed microscopy (PPM) | Certificate of Compliance or Accreditation; PPM certificate for PPM only | Recognize; do not treat PPM as CoW work |
| High complexity | Score >12, or a modified waived method (CMS default) | Certificate of Compliance or Accreditation with high-complexity qualifications | No independent performance |
PPM is a moderate-complexity subset restricted to providers (42 CFR 493.19). It is not a parking place for a modified waived cassette. If you change a waived method, CMS does not recategorize it as moderate or as PPM. AMT's wording is the exam answer: it defaults to high complexity.
The seven CLIA scoring criteria (knowledge; training and experience; reagent preparation; operational steps; calibration/QC/PT materials; troubleshooting; interpretation and judgment) are how FDA and CMS place unmodified commercial methods. You do not rescore a cassette at the chair. You either follow the IFU and keep the FDA waived category, or you have created a high-complexity laboratory-developed modification.
Certificate of Waiver laboratories must follow the IFU exactly
42 CFR 493.15(e) requires CoW laboratories to follow manufacturers' instructions for performing the test. For waived testing, the package insert is the procedure. CoW labs are not inspected on the same routine cycle as accredited laboratories, but CMS may inspect for complaints or to confirm that only waived, unmodified testing is occurring. Performing a nonwaived or modified test on a CoW certificate is a CLIA violation, not a documentation afterthought.
The IFU includes intended use, limitations, specimen types, volumes, timing, temperature, storage, QC, interpretation, and any required confirmatory or supplemental testing (Section 5.3). Skipping a page is still a deviation.
A hospital or clinic that holds a Certificate of Compliance or Certificate of Accreditation still must follow the IFU if it wants the test to remain waived. The larger certificate does not give a CMLA a personal license to modify a kit. If the laboratory has validated a modified method as high complexity, the person who performs it must meet high-complexity testing-personnel rules—not "anyone who can open a pouch."
What counts as off-label or modified use
Off-label use means performing the test in a way the manufacturer and the FDA clearance did not authorize. Modified use is any change to the prescribed system. Both default the test to high complexity.
| Modification | Why it is off-label | Exam-style example |
|---|---|---|
| Extra or shortened incubation / read time | Timing is part of the cleared method | Leaving a strep cassette 10 extra minutes because the line is faint |
| Diluted or concentrated samples | Changes analyte concentration and matrix | Adding saline so a thick specimen will "flow better" |
| Unapproved specimen type | Different matrix and interferents | Serum on a whole-blood-only meter; nasopharyngeal (NP) swab on a throat-only kit |
| Homemade QC | Controls are part of the cleared test system | Mixing leftover positive patient urine as a "positive control" |
| Expired kits or reagents | Stability was validated only through labeled dating | Using last month's influenza kit "just this once" because the shipment is late |
| Wrong volume, temperature, or a reagent from another kit | Alters chemistry and flow | Kit A buffer with Kit B strips; running a refrigerated cassette without the required warm-up |
Using the kit on a population outside intended use (Section 5.2) is the same legal problem: FDA categorization assumed the labeled population. A control line on an expired or modified cassette does not restore waived status.
What jumps when the test becomes high complexity
The category change is not a paperwork footnote. Nonwaived, high-complexity testing triggers CLIA quality-system and personnel subparts.
| Requirement | Waived (unmodified, per IFU) | After modification (high complexity) |
|---|---|---|
| CLIA certificate | CoW may perform it | CoW is not sufficient |
| Laboratory director | CoW director qualifications | High-complexity director (42 CFR 493.1443)—typically a pathologist or other qualified physician, or a doctoral scientist with required certification/experience |
| Testing personnel | No CLIA degree requirement for waived testing personnel | High-complexity testing personnel (42 CFR 493.1489); a CMLA credential alone does not authorize independent high-complexity testing |
| QC | Whatever the IFU requires | Nonwaived QC, generally two control levels each day of patient testing (42 CFR 493.1256) unless an approved equivalent plan applies |
| PT | CLIA does not require PT for waived tests | Enrollment and successful PT when the analyte is in a regulated specialty |
| Validation | Use the manufacturer's claims | Establish performance specifications for the modified method (42 CFR 493.1253) before reporting patients |
A CMLA who "just incubates a little longer" has not created a clever workaround. They have started high-complexity testing without the certificate, director, QC, PT, or validation CLIA requires.
CMLA scope: do not independently perform high-complexity testing
AMT's CMLA competencies are waived and point-of-care performance plus preanalytical and clerical work. You must recognize high-complexity confirmatory names (gas chromatography/mass spectrometry, culture, direct fluorescent antibody) so you can handle and send specimens. You must not independently perform high-complexity testing.
If a provider asks you to "make the kit work" by diluting, substituting a swab, or using an expired box:
- Stop. Do not modify.
- Show the IFU limitation, specimen list, or dating.
- Collect an approved specimen, or refer the test to a laboratory whose CLIA certificate and personnel cover the correct unmodified waived method—or true high-complexity testing if that is what was ordered.
- Document the deviation that was not performed.
Scenario
A waived urine human chorionic gonadotropin (hCG) cassette is negative at the labeled read time. The nurse asks you to "give it another ten minutes." Extra incubation is modified use. The test is no longer waived. You do not have a validated high-complexity hCG method on that cassette. Report only within the IFU window, or collect a new specimen and follow the insert. Do not invent a longer incubation protocol.
Exam traps
- Believing a CMLA or nurse license converts a modified waived test into allowed moderate-complexity testing.
- Treating PPM as the category for extra incubation.
- Assuming a hospital Certificate of Accreditation lets anyone on the shift modify kits.
- Calling leftover-patient "controls" equivalent to manufacturer QC.
- Using an expired kit and calling the result waived because a control line still appeared.
Keep the method waived by doing nothing the IFU does not write down.
Under AMT CMLA I.2.B.1 and CLIA policy, what happens when a waived test system is used off-label or is modified?
Which action is a modified use that defaults a waived cassette to high complexity?
A Certificate of Waiver clinic asks a CMLA to dilute a viscous specimen with saline so a waived cassette will flow. What is the correct action?